Endtidal carbonmonoxide and carboxyhemoglobin for prediction of significant hyperbilirubinemia in healthy Indian neonates >35 weeks of gestation
DOI:
https://doi.org/10.18203/2349-3291.ijcp20202058Keywords:
Carboxyhemoglobin, Early neonatal period, Endtidalcarbonmonoxide corrected, HyperbilirubinemiaAbstract
Background: Endtidalcarbonmonoxide (ETCOc) and Carboxyhemoglobin (COHB) levels correlate well to bilirubin production and an availability of non-invasive point of care (POC) device in predicting significant hyperbilirubinemia is of great advantage when compared to measurement of serum bilirubin. Objective of the study is to measure a value of ETCOc and COHB in the early neonatal period for the prediction of significant hyperbilirubinemia.
Methods: This was the descriptive Cross Sectional Study. ETCOc and COHB were measured 12th hourly for 72 hours followed by TSB in whom the TCB was >14mg/dl. Neonates were classified as jaundiced whose TSB values were in phototherapy range as per AAP Recommendations. Receiver Operative Curves (ROC) were created by appropriate statistical software for ETCOc and COHb to predict significant hyperbilirubinemia. The Sensitivity, Specificity, Positive predictive value, Negative predictive value and likelihood ratios of each was determined and the correlation between ETCOc and COHb levels, ETCOc and TCB, COHB and TCB at different hours of age was evaluated.
Results: Among the total 320 infants, 156 of them developed significant hyperbilirubinemia. The ETCOc and COHB level at 60 hours of age was the most predictive of significant hyperbilirubinemia by ROC analysis. ETCOc cut-off of 1.65 ppm at 60 hours of age has a sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio of 84.6%, 80.5%, 80.5% and 84.6%, 4.33 and 0.19. COHB cut-off of 1.32 ppm at 60 hours of age has a sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio of 84.6%, 81%, 80% and 84.2%, 4.34 and 0.19.ETCOc had a maximum correlation with COHB at 48 hours of age.
Conclusions: An increased level of Endtidalcarbonmonoxide and Carboxyhemoglobin in the early neonatal period is useful as a screening test for prediction of significant hyperbilirubinemia.
References
Bhutani VK, Johnson LH, Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatric Clini North Am. 2004 Aug;51(4):843-61.
Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen‐bjergaard L, Petersen JR, et al. Extreme hyperbilirubinaemia in term and near‐term infants in Denmark. Acta Paediatr. 2005 Jan;94(1):59-64.
Manning D, Todd P, Maxwell M, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonat Edit. 2007 Sep 1;92(5):F342-6.
Engel R. Estimation of heme turnover and erythrocyte survival in man from clearance of bilirubin and from carbon monoxide production. Clin Res. 1969;17:325.
Landaw SA, Callahan EW, Schmid R. Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide. J Clini Investigat. 1970 May 1;49(5):914-25.
Stevenson DK, Ostrander CE, Johnson JD. Effect of erythrocyte destruction on the pulmonary excretion rate of carbon monoxide in adult male Wistar rats. J Lab Clini Medi. 1979 Oct;94(4):649-54.
Vreman HJ, Stevenson DK, Oh W, Fanaroff AA, Wright LL, Lemons JA, et al. Semiportable electrochemical instrument for determining carbon monoxide in breath. Clini Chem. 1994 Oct 1;40(10):1927-33.
Stevenson DK, Vreman HJ, Oh W, Fanaroff AA, Wright LL, Lemons JA, et al. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clini Chem. 1994 Oct 1;40(10):1934-9.
Herschel M, Karrison T, Wen M, Caldarelli L, Baron B. Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs' test with ETCOc for detecting significant jaundice. J Perinatol. 2002 Jul;22(5):341-7.
Smith DW, Hopper AO, Shahin SM, Cohen RS, Ostrander CR, Ariagno RL, et al. Neonatal bilirubin production estimated from" end-tidal" carbon monoxide concentration. J Pediatr Gastroenterol and Nutrit. 1984;3(1):77-80.
Uetani Y, Nakamura H, Okamoto O, Yamazaki T, Vreman HJ, Stevenson DK. Carboxyhemoglobin measurements in the diagnosis of ABO hemolytic disease. Pediatr Int. 1989 Apr;31(2):171-6.
Okuyama H, Yonetani M, Uetani Y, Nakamura H. End‐tidal carbon monoxide is predictive for neonatal non‐hemolytic hyperbilirubinemia. Pediatr Int. 2001 Aug 22;43(4):329-33.
Schutzman DL, Gatien E, Ajayi S, Wong RJ. Carboxyhemoglobin levels as a predictor of risk for significant hyperbilirubinemia in African-American DAT+ infants. J Perinatol. 2016 May;36(5):386-8.
Ostrander CR, Cohen RS, Hopper AO, Cowan BE, Stevens GB, Stevenson DK. Paired determinations of blood carboxyhemoglobin concentration and carbon monoxide excretion rate in term and preterm infants. J Lab Clini Medi. 1982 Nov;100(5):745-55.
